Lantheus (LNTH) Stock Forecast, Price Target & Predictions
LNTH Stock Forecast
Lantheus stock forecast is as follows: an average price target of $155.00 (represents a 67.28% upside from LNTH’s last price of $92.66) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
LNTH Price Target
The average price target for Lantheus (LNTH) is $155.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $175.00 to $125.00. This represents a potential 67.28% upside from LNTH's last price of $92.66.
LNTH Analyst Ratings
According to 6 Wall Street analysts, Lantheus's rating consensus is 'Buy'. The analyst rating breakdown for LNTH stock is 0 'Strong Buy' (0.00%), 6 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Lantheus Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 03, 2024 | Ed Ridley-Day | Redburn Partners | $175.00 | $106.47 | 64.37% | 88.86% |
| Aug 01, 2024 | David Turkaly | JMP Securities | $125.00 | $104.83 | 19.24% | 34.90% |
| Jul 12, 2024 | Anthony Petrone | Mizuho Securities | $165.00 | $123.62 | 33.47% | 78.07% |
| Nov 15, 2022 | Leerink Partners | $120.00 | $57.25 | 109.61% | 29.51% | |
| Aug 05, 2022 | Leerink Partners | $110.00 | $76.25 | 44.26% | 18.71% |
The latest Lantheus stock forecast, released on Sep 03, 2024 by Ed Ridley-Day from Redburn Partners, set a price target of $175.00, which represents a 64.37% increase from the stock price at the time of the forecast ($106.47), and a 88.86% increase from LNTH last price ($92.66).
Lantheus Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 3 |
| Avg Price Target | - | - | $155.00 |
| Last Closing Price | $92.66 | $92.66 | $92.66 |
| Upside/Downside | -100.00% | -100.00% | 67.28% |
In the current month, the average price target of Lantheus stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Lantheus's last price of $92.66. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 16, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Aug 01, 2024 | JMP Securities | Outperform | Outperform | Hold |
| Jul 25, 2024 | B. Riley | Buy | Buy | Hold |
| Jul 10, 2024 | JMP Securities | Outperform | Outperform | Hold |
| May 03, 2024 | Truist Financial | Market Outperform | Market Outperform | Hold |
| May 03, 2024 | Mizuho Securities | Underperform | Underperform | Hold |
| Apr 18, 2024 | B. Riley | Buy | Buy | Hold |
| Feb 23, 2024 | Cowen & Co. | Underperform | Underperform | Hold |
| Feb 23, 2024 | JMP Securities | Market Outperform | Market Outperform | Hold |
| Nov 15, 2022 | SVB Leerink | Outperform | Outperform | Hold |
| Oct 07, 2022 | Goldman Sachs | Buy | Buy | Hold |
| Aug 05, 2022 | SVB Leerink | Outperform | Outperform | Hold |
| May 02, 2022 | SVB Leerink | Outperform | Outperform | Hold |
| Feb 24, 2022 | SVB Leerink | Outperform | Outperform | Hold |
Lantheus's last stock rating was published by Cowen & Co. on Sep 16, 2024. The company gave LNTH a "Buy" rating, the same as its previous rate.
Lantheus Financial Forecast
Lantheus Revenue Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $319.95M | $321.70M | $300.78M | $263.17M | $239.29M | $223.72M | $208.88M | $129.56M | $102.07M | $101.06M | $92.51M | $94.15M | $88.54M |
| Avg Forecast | $544.58M | $513.23M | $481.60M | $450.90M | $438.56M | $429.29M | $424.34M | $412.93M | $405.90M | $394.11M | $394.07M | $380.35M | $377.24M | $371.29M | $382.12M | $349.25M | $339.56M | $314.26M | $305.78M | $280.68M | $244.74M | $228.01M | $204.40M | $165.30M | $111.78M | $97.13M | $94.77M | $87.24M | $92.23M | $91.96M |
| High Forecast | $554.98M | $523.03M | $490.80M | $459.51M | $446.93M | $437.49M | $432.44M | $420.81M | $413.65M | $401.64M | $401.60M | $380.84M | $389.27M | $371.87M | $382.12M | $349.25M | $343.01M | $319.28M | $311.62M | $286.04M | $249.41M | $228.01M | $204.40M | $165.30M | $111.78M | $97.13M | $94.77M | $87.24M | $92.23M | $91.96M |
| Low Forecast | $536.87M | $505.97M | $474.78M | $444.52M | $432.35M | $423.22M | $418.33M | $407.08M | $400.16M | $388.53M | $388.49M | $379.86M | $365.97M | $370.70M | $382.12M | $349.25M | $324.60M | $311.98M | $301.45M | $276.71M | $241.28M | $228.01M | $204.40M | $165.30M | $111.78M | $97.13M | $94.77M | $87.24M | $92.23M | $91.96M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 9 | 4 | 3 | 3 | 6 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.05% | 1.07% | 1.08% | 1.05% | 1.09% | 1.26% | 1.16% | 1.05% | 1.07% | 1.06% | 1.02% | 0.96% |
Lantheus's average Quarter revenue forecast for Dec 23 based on 6 analysts is $339.56M, with a low forecast of $324.60M, and a high forecast of $343.01M. LNTH's average Quarter revenue forecast represents a 6.13% increase compared to the company's last Quarter revenue of $319.95M (Sep 23).
Lantheus EBITDA Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 9 | 4 | 3 | 3 | 6 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $112.36M | $143.93M | $-6.11M | $-173.07M | $98.40M | $75.35M | $70.72M | $-27.28M | $-5.93M | $-16.97M | $25.18M | $8.36M | $3.88M |
| Avg Forecast | $69.10M | $65.12M | $61.11M | $57.22M | $55.65M | $54.47M | $53.84M | $52.40M | $51.51M | $50.01M | $50.00M | $48.26M | $47.87M | $47.11M | $48.49M | $65.80M | $43.09M | $39.88M | $38.80M | $59.82M | $-17.47M | $14.05M | $12.60M | $63.98M | $6.89M | $5.99M | $5.84M | $5.38M | $5.69M | $5.67M |
| High Forecast | $70.42M | $66.37M | $62.28M | $58.31M | $56.71M | $55.51M | $54.87M | $53.40M | $52.49M | $50.96M | $50.96M | $48.33M | $49.39M | $47.19M | $48.49M | $78.96M | $43.53M | $40.51M | $39.54M | $71.78M | $-13.98M | $14.05M | $12.60M | $76.77M | $6.89M | $5.99M | $5.84M | $5.38M | $5.69M | $5.67M |
| Low Forecast | $68.12M | $64.20M | $60.25M | $56.41M | $54.86M | $53.70M | $53.08M | $51.65M | $50.78M | $49.30M | $49.30M | $48.20M | $46.44M | $47.04M | $48.49M | $52.64M | $41.19M | $39.59M | $38.25M | $47.86M | $-20.97M | $14.05M | $12.60M | $51.18M | $6.89M | $5.99M | $5.84M | $5.38M | $5.69M | $5.67M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.82% | 3.71% | -0.10% | 9.90% | 7.00% | 5.98% | 1.11% | -3.96% | -0.99% | -2.91% | 4.68% | 1.47% | 0.68% |
6 analysts predict LNTH's average Quarter EBITDA for Dec 23 to be $43.09M, with a high of $43.53M and a low of $41.19M. This is -61.65% lower than Lantheus's previous annual EBITDA (Sep 23) of $112.36M.
Lantheus Net Income Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 9 | 4 | 3 | 3 | 6 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $131.96M | $94.13M | $-2.81M | $-119.19M | $61.23M | $43.06M | $42.96M | $-40.22M | $-13.41M | $-26.66M | $9.01M | $-3.41M | $-6.39M |
| Avg Forecast | $156.17M | $148.31M | $138.59M | $129.16M | $143.94M | $140.28M | $140.28M | $134.44M | $143.42M | $117.63M | $122.00M | $113.20M | $113.34M | $113.72M | $133.68M | $39.71M | $104.56M | $96.67M | $95.68M | $36.10M | $-25.76M | $58.66M | $49.63M | $38.61M | $11.77M | $4.47M | $3.49M | $56.75M | $841.21K | $-4.10M |
| High Forecast | $160.05M | $152.00M | $142.03M | $132.37M | $147.51M | $143.77M | $143.77M | $137.78M | $146.98M | $120.55M | $125.03M | $114.63M | $126.25M | $114.58M | $133.69M | $47.65M | $112.33M | $98.87M | $99.97M | $43.32M | $-20.61M | $58.66M | $49.63M | $46.33M | $11.77M | $4.47M | $3.49M | $68.10M | $841.21K | $-4.10M |
| Low Forecast | $153.29M | $145.58M | $136.04M | $126.79M | $141.29M | $137.70M | $137.70M | $131.97M | $140.78M | $115.47M | $119.76M | $111.07M | $106.88M | $112.85M | $133.67M | $31.77M | $97.49M | $92.28M | $91.40M | $28.88M | $-30.91M | $58.66M | $49.63M | $30.89M | $11.77M | $4.47M | $3.49M | $45.40M | $841.21K | $-4.10M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.37% | 0.98% | -0.08% | 4.63% | 1.04% | 0.87% | 1.11% | -3.42% | -3.00% | -7.64% | 0.16% | -4.06% | 1.56% |
Lantheus's average Quarter net income forecast for Dec 23 is $104.56M, with a range of $97.49M to $112.33M. LNTH's average Quarter net income forecast represents a -20.76% decrease compared to the company's last Quarter net income of $131.96M (Sep 23).
Lantheus SG&A Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 9 | 4 | 3 | 3 | 6 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $73.14M | $62.61M | $55.89M | $66.62M | $49.17M | $60.09M | $57.94M | $81.95M | $45.74M | $60.81M | $30.31M | $26.54M | $29.83M |
| Avg Forecast | $173.43M | $163.44M | $153.37M | $143.59M | $139.66M | $136.71M | $135.14M | $131.50M | $129.26M | $125.51M | $125.50M | $121.13M | $120.14M | $118.24M | $121.69M | $53.55M | $108.14M | $100.08M | $97.38M | $48.68M | $52.50M | $72.61M | $65.09M | $52.07M | $35.60M | $30.93M | $30.18M | $27.78M | $29.37M | $29.28M |
| High Forecast | $176.74M | $166.56M | $156.30M | $146.34M | $142.33M | $139.32M | $137.72M | $134.01M | $131.73M | $127.91M | $127.89M | $121.28M | $123.97M | $118.43M | $121.69M | $64.26M | $109.24M | $101.68M | $99.24M | $58.42M | $63.00M | $72.61M | $65.09M | $62.48M | $35.60M | $30.93M | $30.18M | $27.78M | $29.37M | $29.28M |
| Low Forecast | $170.97M | $161.13M | $151.20M | $141.56M | $137.69M | $134.78M | $133.22M | $129.64M | $127.43M | $123.73M | $123.72M | $120.97M | $116.54M | $118.05M | $121.69M | $42.84M | $103.37M | $99.35M | $96.00M | $38.95M | $42.00M | $72.61M | $65.09M | $41.65M | $35.60M | $30.93M | $30.18M | $27.78M | $29.37M | $29.28M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.73% | 0.64% | 1.15% | 1.27% | 0.68% | 0.92% | 1.11% | 2.30% | 1.48% | 2.01% | 1.09% | 0.90% | 1.02% |
Lantheus's average Quarter SG&A projection for Dec 23 is $108.14M, based on 6 Wall Street analysts, with a range of $103.37M to $109.24M. The forecast indicates a 47.85% rise compared to LNTH last annual SG&A of $73.14M (Sep 23).
Lantheus EPS Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 9 | 4 | 3 | 3 | 6 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.93 | $1.38 | $-0.04 | $-1.74 | $0.89 | $0.63 | $0.63 | $-0.59 | $-0.20 | $-0.39 | $0.13 | $-0.05 | $-0.10 |
| Avg Forecast | $2.14 | $2.03 | $1.90 | $1.77 | $1.97 | $1.92 | $1.92 | $1.84 | $1.96 | $1.61 | $1.67 | $1.55 | $1.55 | $1.56 | $1.83 | $1.54 | $1.43 | $1.32 | $1.31 | $1.29 | $0.96 | $0.83 | $0.70 | $0.46 | $0.17 | $0.06 | $0.05 | $-0.01 | $0.01 | $-0.06 |
| High Forecast | $2.19 | $2.08 | $1.94 | $1.81 | $2.02 | $1.97 | $1.97 | $1.89 | $2.01 | $1.65 | $1.71 | $1.57 | $1.73 | $1.57 | $1.83 | $1.56 | $1.54 | $1.35 | $1.37 | $1.36 | $0.98 | $0.83 | $0.70 | $0.46 | $0.17 | $0.06 | $0.05 | $-0.01 | $0.01 | $-0.06 |
| Low Forecast | $2.10 | $1.99 | $1.86 | $1.74 | $1.93 | $1.88 | $1.88 | $1.81 | $1.93 | $1.58 | $1.64 | $1.52 | $1.46 | $1.54 | $1.83 | $1.53 | $1.33 | $1.26 | $1.25 | $1.22 | $0.94 | $0.83 | $0.70 | $0.46 | $0.17 | $0.06 | $0.05 | $-0.01 | $0.01 | $-0.06 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.46% | 1.05% | -0.03% | -1.81% | 1.07% | 0.90% | 1.37% | -3.54% | -3.16% | -7.89% | -13.00% | -4.20% | 1.72% |
According to 6 Wall Street analysts, Lantheus's projected average Quarter EPS for Dec 23 is $1.43, with a low estimate of $1.33 and a high estimate of $1.54. This represents a -25.85% decrease compared to LNTH previous annual EPS of $1.93 (Sep 23).
Lantheus Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AVDL | Avadel Pharmaceuticals | $10.73 | $30.00 | 179.59% | Buy |
| AQST | Aquestive Therapeutics | $3.85 | $10.00 | 159.74% | Buy |
| IRWD | Ironwood Pharmaceuticals | $3.53 | $8.50 | 140.79% | Buy |
| DVAX | Dynavax | $12.90 | $29.00 | 124.81% | Buy |
| LNTH | Lantheus | $92.66 | $155.00 | 67.28% | Buy |
| AMPH | Amphastar Pharmaceuticals | $40.85 | $66.00 | 61.57% | Buy |
| ANIP | ANI Pharmaceuticals | $55.83 | $79.00 | 41.50% | Buy |
| COLL | Collegium Pharmaceutical | $30.90 | $42.33 | 36.99% | Buy |
| ALKS | Alkermes | $30.75 | $37.50 | 21.95% | Hold |
| PCRX | Pacira BioSciences | $19.83 | $23.75 | 19.77% | Hold |
| NBIX | Neurocrine Biosciences | $136.69 | $156.14 | 14.23% | Buy |
| CTLT | Catalent | $63.48 | $63.50 | 0.03% | Hold |